Aptabio Therapeutics, Inc.
Clinical trials sponsored by Aptabio Therapeutics, Inc., explained in plain language.
-
New pill for macular degeneration enters first human tests
Disease control Recruiting nowThis early-stage study tests an oral drug called ABF-101 in healthy adults and people with age-related macular degeneration (AMD). The main goal is to check safety and how the body processes the drug. About 68 participants will take either ABF-101 or a placebo to see if it is wel…
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug, APX-343A, alone or with another cancer drug (pembrolizumab) in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Ab…
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC